According to CASI Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is C$32.54 Million. In 2023 the company made a revenue of C$44.93 Million a decrease over the revenue in the year 2022 that were of C$58.49 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.